Registered entities
ICOSAVAX, INC.
Reg. No. 6600913United States
Innovation
18 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 301 times.
| Year | Filings |
|---|---|
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 10 |
| 2025 | 16 |
| 2026 | 4 |
Social engagement
Social engagement: 3.9M social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
15 investors on record; lead investors include RA Capital Management, Qiming.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 9 | 60% |
| Private equity | 2 | 13% |
| Other / undisclosed | 4 | 27% |
Recent activity
30 Jun 2026
Event
AstraZeneca Ambassadors Program 2026/2027
19 Jun 2026
Partnership
Consultorio Amazonas
17 Jun 2026
Recognition